Pascal and Francis Bibliographic Databases

Help

Search results

Your search

is.\*:("EJCODS")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1236

  • Page / 50
Export

Selection :

  • and

Adjuvant chemotherapy for medulloblastoma : the first multi-centre control trial of the international society of paediatric oncology (SIOP I)TAIT, D. M; THORNTON-JONES, H; BLOOM, H. J. G et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 4, pp 464-469, issn 0277-5379Article

Adrenal steroids as parameters of the bioavailability of MA and MPAWILLEMSE, P. H. B; DIKKESCHEI, L. D; TJABBES, T et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 3, pp 359-362, issn 0277-5379Article

Blood levels of reduced and oxidized glutathione in malignant and non-malignant human colorectal lesionsBOISIO, M. L; MERLO, F; MARTINES, H et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 2, pp 89-91, issn 0277-5379Article

Breast conservation and management of early breast cancerYARNOLD, J. R.European journal of cancer & clinical oncology. 1990, Vol 26, Num 6, pp 653-655, issn 0277-5379Article

Cellular retinol binding protein and breast carcinomaMEHTA, R. R; HART, G. D.European journal of cancer & clinical oncology. 1990, Vol 26, Num 8, pp 888-891, issn 0277-5379Article

Cigarette smoking and bladder cancerD'AVANZO, B; NEGRI, E; LA VECCHIA, C et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 6, pp 714-718, issn 0277-5379Article

Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancerHARDY, J. R; POWLES, T. J; JUDSON, I. R et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 7, pp 824-827, issn 0277-5379Article

Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenograftsSCHOLZ, C. C; BERGER, D. P; WINTERHALTER, B. R et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 8, pp 901-905, issn 0277-5379Article

Disposition pharmacokinetics, and metabolism of 14C-fotemustine in cancer patientsINGS, R. M. J; GRAY, A. J; HUGHES, T et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 7, pp 838-842, issn 0277-5379Article

Epidermal growth factor receptor expression and suramin cytotoxicity in vitroOLIVIER, S; FORMENTO, P; FISCHEL, J. L et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 8, pp 867-871, issn 0277-5379Article

Experimental and clinical status of intraperitoneal chemotherapyLOS, G; MCVIE, J. G.European journal of cancer & clinical oncology. 1990, Vol 26, Num 6, pp 755-762, issn 0277-5379Article

Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancerFANTL, V; RICHARDS, M. A; SMITH, R et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 4, pp 423-429, issn 0277-5379Article

High frequency of double drug resistance in the B16 melanoma cell lineMCMILLAN, T. J; KALEBIC, T; STARK, G. R et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 5, pp 565-567, issn 0277-5379Article

Histochemical examination of expression of ras p21 protein and R 1881-binding protein in human prostatic cancersSUMIYA, H; MASAI, M; AKIMOTO, S et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 7, pp 786-789, issn 0277-5379Article

Influence of hormono- and/or chemotheraphy on the MXT mouse mammary tumor as monitored by 31P MRSSCHEIBER, C; KISS, R; DE LAUNOIT, Y et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 3, pp 241-251, issn 0277-5379Article

Misonidazole hypoxic cytotoxicity and chemosensitization in two cell lines with different intracellular glutathione levelsDEGRAFF, W. G; RUSSO, A; FRIEDMAN, N et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 1, pp 17-20, issn 0277-5379Article

Mitotic activity and survival in advanced non-Hodgkin's lymphoma of unfavourable histologyBRANDT, L; JOHNSON, A; OLSSON, H et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 3, pp 227-230, issn 0277-5379Article

Preactivation : a novel antitumour and antiviral approachGULLIYA, K. S; CHANH, T; NEWMAN, J et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 5, pp 551-553, issn 0277-5379Article

Protection of cultured malignant cells from mitoxantrone cytotoxicity by low extracellular pH : a possible mechanism for chemoresistance in vivoJÄHDE, E; GLÜSENKAMP, K.-H; RAJEWSKY, M. F et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 2, pp 101-106, issn 0277-5379Article

Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicityCHAN, T. C. K; HOWELL, S. B.European journal of cancer & clinical oncology. 1990, Vol 26, Num 8, pp 907-911, issn 0277-5379Article

Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanomaPRAYER, L; WINKELBAUER, H; GRITZMANN, N et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 7, pp 827-830, issn 0277-5379Article

Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancerLANGAN-FAHEY, S. M; TORMEY, D. C; JORDAN, V. C et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 8, pp 883-888, issn 0277-5379Article

The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling. II, Prognostic significance in patients treated by chemotherapyPRICE, P; HOGAN, S. J; BLISS, J. M et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 4, pp 453-457, issn 0277-5379Article

Treatment of small-cell carcinoma of the cervix with weekly combination chemotherapyTABBARA, I. A; GROSH, W. A; ANDERSEN, W. A et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 6, pp 748-749, issn 0277-5379Article

The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonistUPWARD, J. W; ARNOLD, B. D. C; LINK, C et al.European journal of cancer & clinical oncology. 1990, Vol 26, pp S12-S15, issn 0277-5379, suppl. 1Conference Paper

  • Page / 50